Labgenomics Co Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

December 21, 2020 December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more. $170M: Israeli ‘Digital Health First’ VC Firm OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spearhead the fund’s expansion into the region’s market. OTV is the only venture capital fund in Israel whose primary focus is digital health, specializing in supporting their portfolio companies reach maturity, refine execution, tackle regulatory hurdles and ensure a global imprint on validated products. Over the course of the past five years, OTV has prioritized investment in digital health

United statesArgyll and buteUnited kingdomUlf landegrenJonathan tischSujit nairRobert valenzuelaJohn shoffnerJasont gammackAsia pacificAndreessen horowitzDavid shawAvinash reddyOncolytic immunotherapiesIntervenn biosciencesSherlock biosciences